Literature DB >> 432557

Lymphocyte studies in rheumatoid arthritis. III. A comparative study of the responses of peripheral blood and synovial fluid lymphocytes to phytomitogens.

V Corrigall, G S Panayi, R Laurent.   

Abstract

The response of peripheral blood and synovial fluid lymphocytes to three non-specific mitogens has been studied. The paired samples were taken from patients with a range of inflammatory arthritides. Unstimulated synovial fluid lymphocytes (SFL) tended to have a greater uptake of tritiated thymidine than had unstimulated peripheral blood lymphocytes (PBL). This background uptake of tritiated thymidine by SFL showed a positive correlation with the response these SFL then showed to the mitogens. A significant depression was observed in the SFL response to phytohaemagglutinin when compared with the paired PBL response; this was seen in both the rheumatoid arthritis and other inflammatory joint diseases groups. SFL responses to concanavalin A and pokeweed mitogen, although depressed in individual cases, failed to show a significant depression overall. Attempts to restore the SFL response to that of the paired PBL by removal of any possible blocking substance from the cell surface either by pre-incubation of SFL in tissue culture medium or by enzyme treatment were unsuccessful. This suggested that cell surface blockers were possibly not the reason for deficient SFL reponses and that other factors were involved.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 432557

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  17 in total

1.  Stimulation of rheumatoid synovial and blood T cells and lines by synovial fluid and interleukin-2: characterization of clones and recognition of a co-stimulatory effect.

Authors:  N Hain; S Alsalameh; W M Bertling; J R Kalden; G R Burmester
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

2.  Synovial fluid mononuclear cells exhibit a spontaneous HLA-DR driven proliferative response.

Authors:  O Duke; Y Gordon; G S Panayi
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

3.  Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  G Lemm; H Warnatz
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

4.  Changes of lymphocyte membrane fluidity in rheumatoid arthritis: a fluorescence polarisation study.

Authors:  E Beccerica; G Piergiacomi; G Curatola; G Ferretti
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

5.  T cell subsets in the blast cell population in phytohemagglutinin-stimulated peripheral blood in vitro and in rheumatoid arthritis synovial fluid in vivo.

Authors:  D Nordström; Y T Konttinen; V Bergroth; M Segerberg-Konttinen; S Santavirta
Journal:  Rheumatol Int       Date:  1987       Impact factor: 2.631

6.  Identification of immunostimulatory dendritic cells in the synovial effusions of patients with rheumatoid arthritis.

Authors:  N J Zvaifler; R M Steinman; G Kaplan; L L Lau; M Rivelis
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

7.  Increased DNA and/or RNA content of synovial fluid cells in rheumatoid arthritis: a flow-cytometry study.

Authors:  B Bonvoisin; G Cordier; J P Revillard; E Lejeune; M Bouvier
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

8.  Indomethacin inhibits in vitro immunoglobulin production by human B-lymphocytes.

Authors:  G S Panayi; N D Staite; A Unger
Journal:  Agents Actions       Date:  1981-12

9.  Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis.

Authors:  A Fontana; H Hengartner; E Weber; K Fehr; P J Grob; G Cohen
Journal:  Rheumatol Int       Date:  1982       Impact factor: 2.631

10.  Expression and function of CD5 and CD28 in patients with rheumatoid arthritis.

Authors:  J Verwilghen; V Corrigall; R M Pope; R Rodrigues; G S Panayi
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.